Whole genome sequencing reveals limited viral diversity in HIV-coinfected adults, indicating HBV genotype impact.
Background The molecular characteristics of hepatitis B virus (HBV) in Africa, including the impact of HIV coinfection, are poorly understood. Methods We performed whole genome sequencing (WGS) on biospecimens collected prior to antiviral therapy in a well-characterized cohort of adults with HBV in Zambia, enriched for HIV coinfection (HBV/HIV). We assessed the frequency of basal core promoter (BCP) and precore variants, substitution frequencies, and the ratio of nonsynonymous to synonymous substitutions (dN/dS ratios), a surrogate for selection pressure. Results Among 215 participants (median age, 33 years, 36% e antigen [HBeAg]-positive, 35% with HBV/HIV), 114 (53.0%) had viral genotype E (gtE) and 101 (47.0%) had genotype A (gtA), subgenotype 1. BCP and precore variants, associated with HBeAg-negativity, were more common with increased age, in the absence of HIV, and with gtE. Distinct from gtA, gtE had dN/dS ratios that were increased in the core versus polymerase region. Low dN/dS ratios were observed in HBV/HIV, especially at the lowest CD4 T cell frequencies. Sequences from acute HBV infection as well as from 5 participants with chronic HBV/HIV who cleared hepatitis B surface antigen early during tenofovir-based antiretroviral therapy showed remarkably low dN/dS ratios. Conclusions HBV gtE exhibited distinct substitution patterns compared to gtA, and HBV/HIV was associated with reduced HBV sequence diversity, consistent with impaired immune pressure.
No takes yet. Share an insight, caveat, or question.
Vinikoor et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: